{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:54:53Z","timestamp":1762869293347,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.htct.2021.08.011","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T13:21:29Z","timestamp":1638278489000},"page":"113-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1541-7952","authenticated-orcid":false,"given":"Thamiris Silva","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7171-560X","authenticated-orcid":false,"given":"Jo\u00e3o S\u00e1vio Silva","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8565-0744","authenticated-orcid":false,"given":"Gabriela Lemes","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.htct.2021.08.011_bib0001","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3390\/cancers12103061","article-title":"Risks of solid and lymphoid malignancies in patients with myeloproliferative neoplasms: clinical implications","volume":"12","author":"Brabrand","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.htct.2021.08.011_bib0002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3324\/haematol.2010.033779","article-title":"Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients","volume":"96","author":"Rumi","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.htct.2021.08.011_bib0003","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1158\/1055-9965.EPI-09-0353","article-title":"Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"18","author":"Vannucchi","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.htct.2021.08.011_bib0004","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.leukres.2015.05.002","article-title":"Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: clinical characteristics, therapy and outcome","volume":"39","author":"Masarova","year":"2015","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.htct.2021.08.011_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/10428194.2015.1071492","article-title":"Risk of second primary malignancies and survival of adult patients with polycythemia vera: a United States population-based retrospective study","volume":"57","author":"Khanal","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.htct.2021.08.011_bib0006","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5306\/wjco.v7.i4.324","article-title":"Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia","volume":"7","author":"Shrestha","year":"2016","journal-title":"World J Clin Oncol"},{"issue":"4","key":"10.1016\/j.htct.2021.08.011_bib0007","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3324\/haematol.2014.115840","article-title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","volume":"100","author":"Verstovsek","year":"2015","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.htct.2021.08.011_bib0008","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3324\/haematol.2019.225839","article-title":"Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort","volume":"105","author":"Holst","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.htct.2021.08.011_bib0009","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1182\/blood-2017-10-810739","article-title":"Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1\/2 inhibitor therapy","volume":"132","author":"Porpaczy","year":"2018","journal-title":"Blood"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921013158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921013158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:27Z","timestamp":1762868127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137921013158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2531137921013158"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2021.08.011","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2021.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}